In the separate enrichment analyses, we confirm that transcripts in both current MDD and responders with CRP > 1 mg/L are enriched in immune-related processes and immunometabolic functions (vs. CRP < 1 mg/L and controls), as well as in MDD CRP < 1 vs. controls (independently of treatment status) and responders vs. non-responders (independently of CRP) (Appendix, Table S8). The gene discussed is CRP; the disease is major depressive disorder.